Active substance
Malathion
- US FDA 3
- UK MHRA 2
- US price lines 1
- NHS prices 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| MALATHION | 0.5% | lotion · topical | COHANCE LIFESCIENCES | Prescription | 23 May 2012 |
| OVIDE | 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | lotion · topical | TARO | Discontinued | 2 Aug 1982 |
| MALATHION | 0.5% | lotion · topical | PHARMOBEDIENT | Discontinued | 6 Mar 2009 |
UK MHRA United Kingdom — marketing authorisations
| Product | Authorisation | Holder | Legal status |
|---|---|---|---|
| DERBAC M LIQUID | PL 01074/0241 | G R LANE HEALTH PRODUCTS LIMITED | P |
| PRIODERM LIQUID | PL 01074/0241 | G R LANE HEALTH PRODUCTS LIMITED | P |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | MALATHION 0.5% LOTION | $3.19135 | per ML | 23 Sep 2026 |
| NHS Drug Tariff | Malathion 0.5% aqueous liquid | £15.96 | 150 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.